Bio-Path Holdings (BPTH) Misses Q1 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. COIN
4. PINS
5. RDDT
6. SNDK
7. FSLR
8. DASH
9. FND
10. RBLX

Go back to Bio-Path Holdings (BPTH) Misses Q1 EPS by 1c

Bio-Path Holdings Reports First Quarter 2016 Financial Results

May 11, 2016 7:30 AM EDT

HOUSTON, May 11, 2016 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the first quarter ended March 31, 2016 and also provided an update on recent corporate developments.

2016 is already proving to be a truly pivotal year for Bio-Path as we advanced our clinical programs and further validated our DNAbilize technology with two important research collaborations, said Peter Nielsen, President and CEO of Bio-Path Holdings. We were pleased to... More